Literature DB >> 16229685

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44.

Alexander Stoeck1, Sascha Keller, Svenja Riedle, Michael P Sanderson, Steffen Runz, Francois Le Naour, Paul Gutwein, Andreas Ludwig, Eric Rubinstein, Peter Altevogt.   

Abstract

Ectodomain shedding is a proteolytic mechanism by which transmembrane molecules are converted into a soluble form. Cleavage is mediated by metalloproteases and proceeds in a constitutive or inducible fashion. Although believed to be a cell-surface event, there is increasing evidence that cleavage can take place in intracellular compartments. However, it is unknown how cleaved soluble molecules get access to the extracellular space. By analysing L1 (CD171) and CD44 in ovarian carcinoma cells, we show in the present paper that the cleavage induced by ionomycin, APMA (4-aminophenylmercuric acetate) or MCD (methyl-beta-cyclodextrin) is initiated in an endosomal compartment that is subsequently released in the form of exosomes. Calcium influx augmented the release of exosomes containing functionally active forms of ADAM10 (a disintegrin and metalloprotease 10) and ADAM17 [TACE (tumour necrosis factor a-converting enzyme)] as well as CD44 and L1 cytoplasmic cleavage fragments. Cleavage could also proceed in released exosomes, but only depletion of ADAM10 by small interfering RNA blocked cleavage under constitutive and induced conditions. In contrast, cleavage of L1 in response to PMA occurred at the cell surface and was mediated by ADAM17. We conclude that different ADAMs are involved in distinct cellular compartments and that ADAM10 is responsible for shedding in vesicles. Our findings open up the possibility that exosomes serve as a platform for ectodomain shedding and as a vehicle for the cellular export of soluble molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16229685      PMCID: PMC1360713          DOI: 10.1042/BJ20051013

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

Review 1.  The L1 family of neural cell adhesion molecules: old proteins performing new tricks.

Authors:  M Hortsch
Journal:  Neuron       Date:  1996-10       Impact factor: 17.173

2.  Purification of ADAM 10 from bovine spleen as a TNFalpha convertase.

Authors:  C A Lunn; X Fan; B Dalie; K Miller; P J Zavodny; S K Narula; D Lundell
Journal:  FEBS Lett       Date:  1997-01-06       Impact factor: 4.124

3.  The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage.

Authors:  S M Pupa; S Ménard; D Morelli; B Pozzi; G De Palo; M I Colnaghi
Journal:  Oncogene       Date:  1993-11       Impact factor: 9.867

Review 4.  Exosome-based immunotherapy.

Authors:  Nathalie Chaput; Julien Taïeb; Noël E C Schartz; Fabrice André; Eric Angevin; Laurence Zitvogel
Journal:  Cancer Immunol Immunother       Date:  2004-01-16       Impact factor: 6.968

5.  Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.

Authors:  Hiroyuki Nakamura; Naoko Suenaga; Kaori Taniwaki; Hirokazu Matsuki; Kayoko Yonezawa; Masato Fujii; Yasunori Okada; Motoharu Seiki
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

6.  The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein.

Authors:  Tobias M J Allinson; Edward T Parkin; Thomas P Condon; Sylva L U Schwager; Edward D Sturrock; Anthony J Turner; Nigel M Hooper
Journal:  Eur J Biochem       Date:  2004-06

7.  Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors.

Authors:  Feras I Hawari; Farshid N Rouhani; Xinle Cui; Zu-Xi Yu; Caitriona Buckley; Maryann Kaler; Stewart J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

8.  Depletion of cellular cholesterol and lipid rafts increases shedding of CD30.

Authors:  Bastian von Tresckow; Karl-Josef Kallen; Elke Pogge von Strandmann; Peter Borchmann; Hans Lange; Andreas Engert; Hinrich P Hansen
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

9.  Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells.

Authors:  Simona Taverna; Giulio Ghersi; Angela Ginestra; Salvatrice Rigogliuso; Sonia Pecorella; Giovanna Alaimo; Francesca Saladino; Vincenza Dolo; Patrizia Dell'Era; Antonio Pavan; Giuseppe Pizzolanti; Paolo Mignatti; Marco Presta; Maria Letizia Vittorelli
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

10.  Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation.

Authors:  Osamu Nagano; Daizo Murakami; Dieter Hartmann; Bart De Strooper; Paul Saftig; Takeshi Iwatsubo; Motowo Nakajima; Masanori Shinohara; Hideyuki Saya
Journal:  J Cell Biol       Date:  2004-06-14       Impact factor: 10.539

View more
  97 in total

1.  Amphiregulin exosomes increase cancer cell invasion.

Authors:  James N Higginbotham; Michelle Demory Beckler; Jonathan D Gephart; Jeffrey L Franklin; Galina Bogatcheva; Gert-Jan Kremers; David W Piston; Gregory D Ayers; Russell E McConnell; Matthew J Tyska; Robert J Coffey
Journal:  Curr Biol       Date:  2011-04-21       Impact factor: 10.834

2.  Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth.

Authors:  Alexander Stoeck; Li Shang; Peter J Dempsey
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

3.  CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.

Authors:  Joel A Mathews; David R Gibb; Bing-Hung Chen; Peggy Scherle; Daniel H Conrad
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

4.  Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.

Authors:  Elham Hosseini-Beheshti; Steven Pham; Hans Adomat; Na Li; Emma S Tomlinson Guns
Journal:  Mol Cell Proteomics       Date:  2012-06-21       Impact factor: 5.911

Review 5.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

6.  Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.

Authors:  Masayuki Shimoda; Simona Principe; Hartland W Jackson; Valbona Luga; Hui Fang; Sam D Molyneux; Yang W Shao; Alison Aiken; Paul D Waterhouse; Christina Karamboulas; Franz M Hess; Takashi Ohtsuka; Yasunori Okada; Laurie Ailles; Andreas Ludwig; Jeffrey L Wrana; Thomas Kislinger; Rama Khokha
Journal:  Nat Cell Biol       Date:  2014-08-24       Impact factor: 28.824

7.  Induction of CD44 cleavage in articular chondrocytes.

Authors:  Nobunori Takahashi; Cheryl B Knudson; Sai Thankamony; Wataru Ariyoshi; Liliana Mellor; Hee-Jeong Im; Warren Knudson
Journal:  Arthritis Rheum       Date:  2010-05

Review 8.  The role of exosomes in the processing of proteins associated with neurodegenerative diseases.

Authors:  Laura J Vella; Robyn A Sharples; Rebecca M Nisbet; Roberto Cappai; Andrew F Hill
Journal:  Eur Biophys J       Date:  2007-12-07       Impact factor: 1.733

9.  Nuclear signalling by tumour-associated antigen EpCAM.

Authors:  Dorothea Maetzel; Sabine Denzel; Brigitte Mack; Martin Canis; Philip Went; Michael Benk; Cuong Kieu; Peer Papior; Patrick A Baeuerle; Markus Munz; Olivier Gires
Journal:  Nat Cell Biol       Date:  2009-01-11       Impact factor: 28.824

10.  Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.

Authors:  Matthias Canault; Aurélie S Leroyer; Franck Peiretti; Guy Lesèche; Alain Tedgui; Bernadette Bonardo; Marie-Christine Alessi; Chantal M Boulanger; Gilles Nalbone
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.